The role of specialty pharmacists and collaboration in improving outcomes
23 January, 2023 by Kristin Michaels, Chief Executive, SHPAJust before we rang in the new year, the refreshed National Medicines Policy was released, governing every aspect of medicines use in Australia.
PSA and PDL team up to support medicine safety
28 November, 2022The Pharmaceutical Society of Australia has entered into a partnership with Pharmaceutical Defence Limited to support pharmacist practice and medicine safety.
Non-medical prescribing will worsen AMR threat: RACGP
18 November, 2022The RACGP warns that allowing more non-medical prescribers in Australia will increase antimicrobial resistance (AMR) — making infections harder to treat.
Trial to allow pharmacists to prescribe medications
16 November, 2022The NSW Government has committed to a 12-month trial allowing pharmacists to prescribe medication and administer more vaccinations.
Pharmacists not immune to workforce issues, but part of the solution: PSA
22 September, 2022 by Dr Fei Sim, National President, Pharmaceutical Society of AustraliaThe indispensable role of pharmacists as primary healthcare providers has been demonstrated through both natural disasters and the pandemic.
New guideline for pharmacists supporting Indigenous Australians
02 August, 2022The PSA has launched guidelines for pharmacists supporting Aboriginal and Torres Strait Islander peoples with medicines management.
Team Medical and PracticeHub partner to improve efficiences
09 May, 2022Healthcare service providers PracticeHub and Team Medical Supplies have joined forces to improve efficiencies.
New pharmacy practice standards for surgical settings
02 May, 2022The SHPA has released the first Australian pharmacy practice standard for surgery and perioperative medicine.
Funding to support on-site pharmacists in residential aged-care facilities
25 March, 2022The government has announced $345.7m funding for on-site pharmacists and community pharmacy services in government-funded residential aged care facilities (RACFs).
Hospital pharmacists' role in COVID-19 treatments
23 March, 2022 by Kristin Michaels, SHPA Chief ExecutiveThe introduction of oral antiviral treatments calls on the expertise and services of hospital pharmacists as we progress towards the endemic stage of this pandemic.
WA pharmacist recognised for leadership, contribution to medical safety
16 March, 2022Kerry Fitzsimons has been recognised by the Society of Hospital Pharmacists of Australia (SHPA) for her leadership and contribution to medical safety in Western Australia and beyond.
SHPA releases pharmacy standard for heart disease
08 March, 2022The new pharmacy practice standard recommends patient to pharmacist ratios and quality improvement indicators specific to specialist cardiology pharmacists.
Royal Victorian Eye and Ear Hospital implements PSML
07 March, 2022The Royal Victorian Eye and Ear Hospital is said to be the first hospital in Australia to implement the Pharmacist Shared Medicines List medicine safety initiative.
New rare blood disease treatment on PBS
28 February, 2022Ultomiris (ravulizumab) will be listed for the first time for patients with paroxysmal nocturnal haemoglobinuria.
Bill to shore up medicine supplies: SHPA
03 December, 2021The Society of Hospital Pharmacists of Australia (SHPA) has welcomed new federal government legislation to further mitigate the impact of medicine shortages on Australians and ensure new and innovative medicines are accessible, available and affordable.
